ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. MGNX, a biopharmaceutical firm centered on growing, manufacturing and commercializing revolutionary monoclonal antibody-based therapeutics for the remedy of most cancers, in the present day introduced that the Firm’s administration will take part within the following investor conferences in March:
- TD Cowen 45th Annual Healthcare Convention (Boston). MacroGenics’ President & Chief Government Officer, Scott Koenig, M.D., Ph.D., will take part in a hearth chat on Wednesday, March 5, 2025, at 10:30am ET. MacroGenics’ administration may even take part in one-on-one conferences.
- Leerink Companions 2025 International Healthcare Convention (Miami). Dr. Koenig will take part in a hearth chat on Tuesday, March 11, 2025, at 11:20am ET. MacroGenics’ administration may even take part in one-on-one conferences.
- Barclays 27th International Healthcare Convention (Miami). Dr. Koenig will take part in a hearth chat on Wednesday, March 12, 2025, at 2:00pm ET. MacroGenics’ administration may even take part in one-on-one conferences.
Webcasts of the above displays could also be accessed underneath “Occasions & Displays” within the Investor Relations part of MacroGenics’ web site at http://ir.macrogenics.com/events.cfm. The Firm will preserve archived replays of those webcasts on its web site for 30 days.
About MacroGenics, Inc.
MacroGenics (the Firm) is a biopharmaceutical firm centered on discovering, growing, manufacturing and commercializing revolutionary monoclonal antibody-based therapeutics for the remedy of most cancers. The Firm generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based know-how platforms, which have applicability throughout broad therapeutic domains. The mix of MacroGenics’ know-how platforms and protein engineering experience has allowed the Firm to generate promising product candidates and enter into a number of strategic collaborations with world pharmaceutical and biotechnology corporations. For extra data, please see the Firm’s web site at www.macrogenics.com. MacroGenics and the MacroGenics emblem are logos or registered logos of MacroGenics, Inc.
Contacts: Jim Karrels, Senior Vice President, CFO 1-301-251-5172 [email protected] Argot Companions 1-212-600-1902 [email protected]
Market Information and Information delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
